ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1735

Endocrine Disruptors Exacerbates Osteoarthritis Pain And Inflammation

Elise Herardot1, Nadine Soliman1, Audrey Pigenet1, Ilana Slotine1, Anni Herranan2, Samia Bahieddine1, Jean-Baptiste Fini2, Olivier Tabary1, Adeline Cambon3, Xavier HOUARD4, Francis BERENBAUM5, SELLAM JEREMIE6 and Alice Courties7, 1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France, Paris, France, 2UMR 7221, Phyma, CNRS–Muséum National d’Histoire Naturelle, Sorbonne Université, 75005 Paris, France, Paris, France, 3Department of Orthopedic, Trauma and Hand Surgery, Hôpital Saint-Antoine, Sorbonne University, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France, Paris, France, 4Centre de Recherche Saint-Antoine, UMR_S938 INSERM /Sorbonne Université, Paris, France, PARIS, France, 5Sorbonne University/Inserm/AP-HP/4Moving Biotech, Paris, France, 6Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France, /Rheumatology Department, AP-HP Saint-Antoine Hospital, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France., Paris, France, 7Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012, Paris, France / Rheumatology Department, AP-HP Saint-Antoine Hospital, 184, rue du Faubourg Saint-Antoine, 75012, Paris, France, Paris, France

Meeting: ACR Convergence 2025

Keywords: Animal Model, cartilage, Drug toxicity, Inflammation, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: Abstracts: Osteoarthritis & Joint Biology – Basic Science (1734–1739)

Session Type: Abstract Session

Session Time: 10:15AM-10:30AM

Background/Purpose: Osteoarthritis (OA) affects over 590 million individuals globally. Epidemiological data suggest that exposure to environmental pollutants, particularly endocrine-disrupting chemicals (EDCs) such as phthalates, PFAS, and heavy metals, may contribute to increased OA risk and severity (1). Chronic exposure to these compounds begins as early as in utero and continues throughout life via environmental and household sources with at least 14 EDCs ubiquitously present in daily life (2). Several have also been identified in the synovial fluid of OA patients, indicating both systemic and local joint exposure. Yet, their functional role in pain modulation and joint inflammation remains insufficiently understood This study aimed to determine whether local and/or systemic low-dose exposure to a mixture of 14 EDCs modulates OA severity and pain, and to explore potential effects on sensory neuron.

Methods: Male and female 12-week-old C57BL/6 mice were exposed either locally by intra-articular (IA) injections of an EDCs mix (e.g., Perfluorooctanoic acid [PFOA]=10⁻⁷M) or vehicle, one week before and after OA induction by IA injection of monoiodoacetate. An additional cohort was systemically (via lifelong administration through drinking water) exposed to the EDCs mix from in utero through 15 weeks. Pain-related behaviour, locomotor activity, and body weight were monitored over 21 days. Histological and molecular analyses were performed on knee joints and dorsal root ganglia (DRG). In vitro, primary DRG neurons from male mice were treated with the EDCs mix (e.g., [PFOA]=10⁻⁸M or 10⁻⁹M), and calcium responses to capsaicin (TRPV1 agonist) were recorded.

Results: In male mice, local IA EDCs exposure significantly increase OA-related pain over the 21-day period (p< 0.001) and reduce the physical activity (day 21: mean [SEM] 13.2m [4.7] vs. 17.4m [2.3] in controls, p< 0.05). Histological analysis revealed more severe synovitis (Krenn score) (5.1 [1.55] vs. 4.3 [1.5], p< 0.05) and OARSI cartilage damage (3 [0.75] vs. 2.5 [2.94], p=0.03). Enhanced macrophage infiltration and elevated Bdnf gene expression in the DRG were also observed. In contrast, female mice with IA EDCs exposure did not display significant mechanical hypersensitivity, although they exhibited reduced physical activity (day 21: 13.5m [1.4] vs 19.5m [2.3] in controls, p< 0.05) along with upregulation of Bdnf expression in DRGs.Male mice exposed systemically to EDCs via drinking water developed persistent OA pain-related behaviours (p=0.001) and unexpectedly showed increased physical activity (16.9m [181.0] vs. 13.6m [127.8], p< 0.05), potentially reflecting EDCs-induced anxiety. No significant effects were observed in female mice. In vitro, EDCs-treated sensory neurons displayed altered calcium dynamics with prolonged depolarization following capsaicin stimulation.

Conclusion: This study reveals that low-dose exposure to EDCs can amplify OA-related pain and inflammatory responses in a sex-specific manner. This study supports the role of EDCs in modulating neuroimmune interactions and sensory neuron excitability in OA pathophysiology. < !(1) Deprouw C, RMD Open. 2022< !(2) Woodruff, Environmental health perspectives. 2011


Disclosures: E. Herardot: Ffizer, 5, Fondation pour la recherhce médicale, 5; N. Soliman: La société Française de Rhumatologie, 5; A. Pigenet: None; I. Slotine: None; A. Herranan: None; S. Bahieddine: None; J. Fini: None; O. Tabary: None; A. Cambon: None; X. HOUARD: None; F. BERENBAUM: 4Moving Biotech, 2, 8, 10; S. JEREMIE: None; A. Courties: Dreamer, 5, Sorbonne Université, 5.

To cite this abstract in AMA style:

Herardot E, Soliman N, Pigenet A, Slotine I, Herranan A, Bahieddine S, Fini J, Tabary O, Cambon A, HOUARD X, BERENBAUM F, JEREMIE S, Courties A. Endocrine Disruptors Exacerbates Osteoarthritis Pain And Inflammation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/endocrine-disruptors-exacerbates-osteoarthritis-pain-and-inflammation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endocrine-disruptors-exacerbates-osteoarthritis-pain-and-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology